Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transfusion-dependent Anemia Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Cell Therapy
1.2.3 Medication
1.2.4 Others
1.3 Market by Application
1.3.1 Global Transfusion-dependent Anemia Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Ambulatory Surgery Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transfusion-dependent Anemia Treatment Market Perspective (2018-2033)
2.2 Transfusion-dependent Anemia Treatment Growth Trends by Region
2.2.1 Global Transfusion-dependent Anemia Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Transfusion-dependent Anemia Treatment Historic Market Size by Region (2018-2023)
2.2.3 Transfusion-dependent Anemia Treatment Forecasted Market Size by Region (2024-2033)
2.3 Transfusion-dependent Anemia Treatment Market Dynamics
2.3.1 Transfusion-dependent Anemia Treatment Industry Trends
2.3.2 Transfusion-dependent Anemia Treatment Market Drivers
2.3.3 Transfusion-dependent Anemia Treatment Market Challenges
2.3.4 Transfusion-dependent Anemia Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transfusion-dependent Anemia Treatment Players by Revenue
3.1.1 Global Top Transfusion-dependent Anemia Treatment Players by Revenue (2018-2023)
3.1.2 Global Transfusion-dependent Anemia Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Transfusion-dependent Anemia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transfusion-dependent Anemia Treatment Revenue
3.4 Global Transfusion-dependent Anemia Treatment Market Concentration Ratio
3.4.1 Global Transfusion-dependent Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transfusion-dependent Anemia Treatment Revenue in 2022
3.5 Transfusion-dependent Anemia Treatment Key Players Head office and Area Served
3.6 Key Players Transfusion-dependent Anemia Treatment Product Solution and Service
3.7 Date of Enter into Transfusion-dependent Anemia Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transfusion-dependent Anemia Treatment Breakdown Data by Type
4.1 Global Transfusion-dependent Anemia Treatment Historic Market Size by Type (2018-2023)
4.2 Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Type (2024-2033)
5 Transfusion-dependent Anemia Treatment Breakdown Data by Application
5.1 Global Transfusion-dependent Anemia Treatment Historic Market Size by Application (2018-2023)
5.2 Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Transfusion-dependent Anemia Treatment Market Size (2018-2033)
6.2 North America Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023)
6.4 North America Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transfusion-dependent Anemia Treatment Market Size (2018-2033)
7.2 Europe Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023)
7.4 Europe Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size (2018-2033)
8.2 Asia-Pacific Transfusion-dependent Anemia Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transfusion-dependent Anemia Treatment Market Size (2018-2033)
9.2 Latin America Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023)
9.4 Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size (2018-2033)
10.2 Middle East & Africa Transfusion-dependent Anemia Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird bio, Inc.
11.1.1 Bluebird bio, Inc. Company Detail
11.1.2 Bluebird bio, Inc. Business Overview
11.1.3 Bluebird bio, Inc. Transfusion-dependent Anemia Treatment Introduction
11.1.4 Bluebird bio, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023)
11.1.5 Bluebird bio, Inc. Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Detail
11.2.2 Novartis AG Business Overview
11.2.3 Novartis AG Transfusion-dependent Anemia Treatment Introduction
11.2.4 Novartis AG Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023)
11.2.5 Novartis AG Recent Development
11.3 Takeda Pharmaceuticals
11.3.1 Takeda Pharmaceuticals Company Detail
11.3.2 Takeda Pharmaceuticals Business Overview
11.3.3 Takeda Pharmaceuticals Transfusion-dependent Anemia Treatment Introduction
11.3.4 Takeda Pharmaceuticals Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023)
11.3.5 Takeda Pharmaceuticals Recent Development
11.4 Acceleron Pharma, Inc.
11.4.1 Acceleron Pharma, Inc. Company Detail
11.4.2 Acceleron Pharma, Inc. Business Overview
11.4.3 Acceleron Pharma, Inc. Transfusion-dependent Anemia Treatment Introduction
11.4.4 Acceleron Pharma, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023)
11.4.5 Acceleron Pharma, Inc. Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Transfusion-dependent Anemia Treatment Introduction
11.5.4 Celgene Corporation Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023)
11.5.5 Celgene Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Transfusion-dependent Anemia Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Medication
Table 4. Key Players of Others
Table 5. Global Transfusion-dependent Anemia Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Transfusion-dependent Anemia Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Transfusion-dependent Anemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Transfusion-dependent Anemia Treatment Market Share by Region (2018-2023)
Table 9. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Transfusion-dependent Anemia Treatment Market Share by Region (2024-2033)
Table 11. Transfusion-dependent Anemia Treatment Market Trends
Table 12. Transfusion-dependent Anemia Treatment Market Drivers
Table 13. Transfusion-dependent Anemia Treatment Market Challenges
Table 14. Transfusion-dependent Anemia Treatment Market Restraints
Table 15. Global Transfusion-dependent Anemia Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Transfusion-dependent Anemia Treatment Market Share by Players (2018-2023)
Table 17. Global Top Transfusion-dependent Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion-dependent Anemia Treatment as of 2022)
Table 18. Ranking of Global Top Transfusion-dependent Anemia Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Transfusion-dependent Anemia Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Transfusion-dependent Anemia Treatment Product Solution and Service
Table 22. Date of Enter into Transfusion-dependent Anemia Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Transfusion-dependent Anemia Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Type (2024-2033)
Table 28. Global Transfusion-dependent Anemia Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Transfusion-dependent Anemia Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Transfusion-dependent Anemia Treatment Revenue Market Share by Application (2024-2033)
Table 32. North America Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. Bluebird bio, Inc. Company Detail
Table 48. Bluebird bio, Inc. Business Overview
Table 49. Bluebird bio, Inc. Transfusion-dependent Anemia Treatment Product
Table 50. Bluebird bio, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023) & (US$ Million)
Table 51. Bluebird bio, Inc. Recent Development
Table 52. Novartis AG Company Detail
Table 53. Novartis AG Business Overview
Table 54. Novartis AG Transfusion-dependent Anemia Treatment Product
Table 55. Novartis AG Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023) & (US$ Million)
Table 56. Novartis AG Recent Development
Table 57. Takeda Pharmaceuticals Company Detail
Table 58. Takeda Pharmaceuticals Business Overview
Table 59. Takeda Pharmaceuticals Transfusion-dependent Anemia Treatment Product
Table 60. Takeda Pharmaceuticals Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023) & (US$ Million)
Table 61. Takeda Pharmaceuticals Recent Development
Table 62. Acceleron Pharma, Inc. Company Detail
Table 63. Acceleron Pharma, Inc. Business Overview
Table 64. Acceleron Pharma, Inc. Transfusion-dependent Anemia Treatment Product
Table 65. Acceleron Pharma, Inc. Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023) & (US$ Million)
Table 66. Acceleron Pharma, Inc. Recent Development
Table 67. Celgene Corporation Company Detail
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation Transfusion-dependent Anemia Treatment Product
Table 70. Celgene Corporation Revenue in Transfusion-dependent Anemia Treatment Business (2018-2023) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transfusion-dependent Anemia Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Transfusion-dependent Anemia Treatment Market Share by Type: 2022 VS 2033
Figure 3. Cell Therapy Features
Figure 4. Medication Features
Figure 5. Others Features
Figure 6. Global Transfusion-dependent Anemia Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Transfusion-dependent Anemia Treatment Market Share by Application: 2022 VS 2033
Figure 8. Hospital Case Studies
Figure 9. Ambulatory Surgery Center Case Studies
Figure 10. Others Case Studies
Figure 11. Transfusion-dependent Anemia Treatment Report Years Considered
Figure 12. Global Transfusion-dependent Anemia Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Transfusion-dependent Anemia Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Transfusion-dependent Anemia Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Transfusion-dependent Anemia Treatment Market Share by Players in 2022
Figure 16. Global Top Transfusion-dependent Anemia Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transfusion-dependent Anemia Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Transfusion-dependent Anemia Treatment Revenue in 2022
Figure 18. North America Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Transfusion-dependent Anemia Treatment Market Share by Country (2018-2033)
Figure 20. United States Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Transfusion-dependent Anemia Treatment Market Share by Country (2018-2033)
Figure 24. Germany Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Transfusion-dependent Anemia Treatment Market Share by Region (2018-2033)
Figure 32. China Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Transfusion-dependent Anemia Treatment Market Share by Country (2018-2033)
Figure 40. Mexico Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Transfusion-dependent Anemia Treatment Market Share by Country (2018-2033)
Figure 44. Turkey Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Transfusion-dependent Anemia Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Bluebird bio, Inc. Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2018-2023)
Figure 47. Novartis AG Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2018-2023)
Figure 48. Takeda Pharmaceuticals Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2018-2023)
Figure 49. Acceleron Pharma, Inc. Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2018-2023)
Figure 50. Celgene Corporation Revenue Growth Rate in Transfusion-dependent Anemia Treatment Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed